BREAST FIBROSIS

This adverse event was reported 128 times

BREAST FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 L-TRYPTOPHAN 1 0.0023
1 ALENDRONATE SODIUM AND CHOLECALCIFEROL 5 0.0018
2 ERYTHROMYCIN ETHYLSUCCINATE 1 0.0016
3 TAMOXIFEN CITRATE 5 0.0009
4 AMPICILLIN SODIUM AND SULBACTAM SODIUM 2 0.0008
5 GADOTERIDOL 1 0.0006
6 CEFADROXIL 1 0.0005
7 MILK THISTLE 1 0.0005
8 GADOBENATE DIMEGLUMINE 2 0.0005
9 NITROUS OXIDE 1 0.0005
See all drugs enriched for association with BREAST FIBROSIS

BREAST FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 Calcitonin [EPC] 1 0.0003
2 Paramagnetic Contrast Agent [EPC] 1 0.0002
3 Provitamin D2 Compound [EPC] 6 0.0002
4 Estrogen Receptor Antagonist [EPC] 5 0.0001
5 Aromatase Inhibitor [EPC] 14 0.0001
6 Estrogen [EPC] 22 0.0001
7 Vitamin K [EPC] 1 0.0001
8 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
9 Barbiturate [EPC] 1 0.0001
See all drug classes enriched for association with BREAST FIBROSIS